Hülya Över Hamzaoğlu

Clinical Characteristics of Inflammatory Bowel Disease in Turkey

Nurdan Tözün, Özlen Atuğ, Neşe İmeryüz et al. · Journal of Clinical Gastroenterology · 2008 · 75 citations

Medicine, Clinical Sciences, Internal Medicine +9

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G. Feagan et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 70 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +6

Safety of infliximab in Crohnʼs disease

Hülya Över Hamzaoğlu, Julian C. Cooper, Mazen Alsahli et al. · Inflammatory Bowel Diseases · 2010 · 38 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

Oya Yönal, Fatih Eren, Özlen Atuğ et al. · Journal of Crohn s and Colitis · 2011 · 27 citations · Full text

Veterinary Medicine, Immunology, Immunopathology +15

Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease

Hakan Akın, Filiz Türe Özdemir, Fatih Eren et al. · Journal of Crohn s and Colitis · 2010 · 21 citations · Full text

Medicine, Genetics, Molecular Genetics +14